Compounded GLP-1 Injections Recalled Over Sterility Concerns: What Patients Should Know
GLP-1 medications for weight loss and diabetes are some of the most talked about drugs in the country. Some people get them through compounding pharmacies instead of buying the brand name versions. Recent FDA recall notices are a reminder to know exactly where your medicine comes from and how it was made.
What Happened
According to Fox Business, Apothecary Pharma, a North Carolina company, is recalling 22 vials of compounded tirzepatide injection and one vial of NAD+ injection that were distributed nationwide because "their sterility cannot be assured," according to the FDA. Tirzepatide is the active ingredient in the brand name drugs Zepbound and Mounjaro. USA TODAY, as republished by Money Talks News, reported that the voluntary recall began on September 24, 2026, and that the FDA classified it as Class II.
The affected tirzepatide is an 18 mg/mL injection in a 4 mL multidose vial with beyond use dates from October 7 through November 26, 2026. Both outlets report that Apothecary Pharma received an FDA warning letter in December 2025 that cited serious deficiencies in how it produced drugs meant to be sterile.
This is not the only recent recall. The MedShadow Foundation, which tracks FDA enforcement reports, listed other September 2026 recalls of compounded GLP-1 products, including compounded semaglutide and tirzepatide from Carolina Infusion, LLC and compounded tirzepatide from Houston RX LLC, each tied to concerns about sterility.
The FDA notice did not identify any reported illnesses or injuries linked to the Apothecary Pharma recall, according to Fox Business.
Why This Matters
A drug that goes into the body through a needle needs to be sterile. When sterility cannot be assured, there is a risk that bacteria or other contaminants could be present. That can lead to infection at the injection site or, in rare cases, more serious illness.
Compounded drugs are different from brand name drugs in an important way. As USA TODAY reported, compounded formulations are not evaluated by the FDA for purity, safety or effectiveness in the same way approved drugs are. That does not mean every compounded drug is unsafe. It does mean patients should ask good questions.
Class II is the middle level of FDA recall. It means use of the product may cause temporary or medically reversible health problems, and the chance of serious harm is considered remote. Even so, patients should take every recall seriously and check their medicine.
The Legal Issues in Plain Language
Duty to Make Safe Medicine
Pharmacies and drug makers have a duty to prepare medicine safely. For sterile injections, that includes clean rooms, proper equipment and careful testing. When a company falls short and a patient is harmed, the patient may have a claim based on negligence.
Product Liability and Failure to Warn
Drugs are products. In Alabama, people hurt by unreasonably dangerous products may bring claims under the Alabama Extended Manufacturer's Liability Doctrine, along with negligence and warranty claims. Claims can also involve failure to warn, which means a company did not give clear information about a known risk.
What a Recall Does and Does Not Prove
A recall is a safety step. It does not prove that any specific person was hurt by a product. If someone develops an infection or other problem after using a recalled drug, doctors and lawyers would need to look closely at the medical records and the product to understand what happened.
Steps to Take If You Use a Compounded GLP-1
- Check your vial or pharmacy records for the company name, lot number and beyond use date, and compare them with the FDA recall listing.
- If your product is affected, stop using it and contact your pharmacist or prescriber, as the FDA notice advises.
- Watch for warning signs. Fox Business reported that patients should seek medical advice if they develop fever, redness, swelling or worsening pain after an affected injection.
- Keep the vial, packaging and any paperwork. Do not throw them away until you have talked with your doctor and, if you were hurt, a lawyer.
- Report any side effect to the FDA MedWatch program. This helps protect other patients.
- Ask your prescriber where your medicine is made and whether the pharmacy is licensed and inspected.
- If you believe a medicine hurt you, talk with a lawyer soon. Deadlines to file can be short.
Frequently Asked Questions
Why was compounded tirzepatide recalled?
According to the FDA, as reported by Fox Business, Apothecary Pharma recalled 22 vials of compounded tirzepatide because their sterility cannot be assured. The FDA classified the recall as Class II, and the notice did not identify any reported illnesses or injuries.
What should I do if I have a recalled GLP-1 injection?
Stop using the affected product and contact your pharmacist or prescriber. Seek medical advice if you develop fever, redness, swelling or worsening pain after an injection. Keep the vial and packaging and report any side effects to FDA MedWatch.
Are compounded GLP-1 drugs the same as Ozempic, Wegovy, Zepbound or Mounjaro?
No. Compounded versions are made by compounding pharmacies and are not FDA approved. They are not reviewed by the FDA for purity, safety or effectiveness in the same way as brand name drugs. Talk with your doctor about the right option for you.
We Are Here to Help
If you or someone you love was hurt in a similar situation, the team at Heninger Garrison Davis can help you understand your options. Call for a free consultation.
Disclaimer
This article is for general information only and is not legal advice. Reading it does not create an attorney client relationship. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.
